
### [MONDO:0000423](http://purl.obolibrary.org/obo/MONDO_0000423)
**Label:** coenzyme Q10 deficiency disease

**Subclasses:** [MONDO:0013840](http://purl.obolibrary.org/obo/MONDO_0013840) (encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome), [MONDO:0013838](http://purl.obolibrary.org/obo/MONDO_0013838) (coenzyme Q10 deficiency, primary, 3), [MONDO:0012784](http://purl.obolibrary.org/obo/MONDO_0012784) (autosomal recessive ataxia due to ubiquinone deficiency), [MONDO:0011829](http://purl.obolibrary.org/obo/MONDO_0011829) (coenzyme Q10 deficiency, primary, 1), [MONDO:0014562](http://purl.obolibrary.org/obo/MONDO_0014562) (neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome), [MONDO:0013836](http://purl.obolibrary.org/obo/MONDO_0013836) (familial steroid-resistant nephrotic syndrome with sensorineural deafness), [MONDO:0013837](http://purl.obolibrary.org/obo/MONDO_0013837) (deafness-encephaloneuropathy-obesity-valvulopathy syndrome), [MONDO:0014754](http://purl.obolibrary.org/obo/MONDO_0014754) (coenzyme Q10 deficiency, primary, 8; COQ10D8), 

**Corr. equiv. classes:** [Orphanet:319678](http://www.orpha.net/ORDO/Orphanet_319678), [OMIM:607426](http://purl.obolibrary.org/obo/OMIM_607426), [Orphanet:254898](http://www.orpha.net/ORDO/Orphanet_254898), [Orphanet:139485](http://www.orpha.net/ORDO/Orphanet_139485), [OMIM:616276](http://purl.obolibrary.org/obo/OMIM_616276), [OMIM:614652](http://purl.obolibrary.org/obo/OMIM_614652), [Orphanet:457185](http://www.orpha.net/ORDO/Orphanet_457185), [OMIM:614650](http://purl.obolibrary.org/obo/OMIM_614650), [OMIM:614651](http://purl.obolibrary.org/obo/OMIM_614651), [OMIM:614654](http://purl.obolibrary.org/obo/OMIM_614654), [OMIM:616733](http://purl.obolibrary.org/obo/OMIM_616733), [OMIM:612016](http://purl.obolibrary.org/obo/OMIM_612016), [Orphanet:280406](http://www.orpha.net/ORDO/Orphanet_280406), 

**Class expressions from DL-Learner:**

- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 32.70%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 32.21%
- Thing 32.21%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 32.21%
- [HP:0001941](http://purl.obolibrary.org/obo/HP_0001941) (Acidosis) 30.40%
- [HP:0004360](http://purl.obolibrary.org/obo/HP_0004360) (Abnormality of acid-base homeostasis) 30.04%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 29.47%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) 25.42%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 25.26%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 24.70%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 18.05%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 17.29%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 17.27%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) 17.26%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 17.00%


